Sulindac and Breast Density in Women at Risk of Developing Breast Cancer

NCT04542135 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Sulindac Pill
DRUG: Placebo

Sponsor

Alison Stopeck

Collaborators

[object Object]
[object Object]